Amrutanjan Health Care Ltd Share Price Today: Live Updates & Key Insights
Get insights on Amrutanjan Health Care Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Amrutanjan Health Care Ltd
Amrutanjan Health Care Ltd Fundamentals
Amrutanjan Health Care Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Amrutanjan Health Care Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Amrutanjan Health Care Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
Amrutanjan Health Care Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Amrutanjan Health Care Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Amrutanjan Health Care Ltd Technical Details
Amrutanjan Health Care Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Amrutanjan Health Care Ltd Corporate Actions
Amrutanjan Health Care Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Amrutanjan Health Care Ltd’s capital allocation strategies.
Amrutanjan Health Care Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Amrutanjan Health Care Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Amrutanjan Health Care Ltd's relative performance and valuation against major competitors.
Amrutanjan Health Care Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Amrutanjan Health Care Ltd, across its operating activities, investing activities, and financing activities.
Amrutanjan Health Care Ltd Shareholding Pattern
This shows the ownership breakdown of Amrutanjan Health Care Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
About Amrutanjan Health Care Ltd
Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages & hygiene and services in pain management.Amrutanjan has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called 'Cold Snap Gel' and also a mint called 'tingle'. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%.Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company.'Diakyur' for the treatment of Diabetes was introduced during 2000-2001. The name of Company changed from Amrutanjan Limited to Amrutanjan Health Care Limited during the year 2007-08. During the year 2009-10, the name of the Fine Chemicals Division of the Company was changed to Pharmaessense Chemistry Services Division.During April 2011 a new division under the name Amrutanjan Pain Management Center also known as CARE Specialized Pain Management Center was launched in Chennai. The Pharmaessense Chemistry Services Division was transferred to a wholly owned Subsidiary Company viz., Amrutanjan Pharmaessense Private Limited with all its assets and liabilities, excluding land during May 2011. Siva's Soft Drink Private Limited was acquired during February 2011 by way of transfer of shares. The Company launched Amrutanjan Headache Faster Relaxation Roll-on 10ml SKU; launched Amrutanjan Faster Relaxation Balm(white) during the year 2014-15.In FY 2016-17, the Subsidiary Company, Amrutanjan Pharmaessense Private Limited (Transferor Company) got merged with the Holding Company (M/s. Amrutanjan Health Care Limited/ Transferee Company), through Scheme of Amalgamation, effective from 1st July 2016. Accordingly, the assets and liabilities of Amrutanjan Pharmaessense Pvt Ltd as at 01st July, 2016 was taken over by the Company.Amrutanjan Comfy Snug Fit Sanitary napkin was launched in 2016-17. Comfy Snug Fit was launched in 2016. The New Maha Strong Pain Balm was re-launched in 2016. Orange variant was launched in addition to existing Apple variant during financial year 2018-19. The flavour Alphonso, the `King of Mangoes', was launched in 200 ml Ready- to- drink recyclable PET format. Two more new variants, Comfy XLand Comfy Ultra were launched during 2019-20. The Company re-launched its headache Pain balm in 2021-22. It introduced Amrutanjan Comfy Sung Fit Regular Cottony in FY22. A new product, 'Amrutanjan Stop Pain Dental Gel' was launched for Oral Health Care in 2023. In FY 2024, it launched Pain cream and Electro Plus Lemon and Low-sugar variants.In FY 2025, Company launched Amrutanjan Faster Relaxation Roll-on (AFRR) 2.5ml for pain relief. To address hydration and wellness, Electro+ expanded with two scientifically backed solutions: Electro+ Tetra and Electro+ Powder, both formulated with the WHO-recommended formula to address dehydration from conditions such as diarrhoea and vomiting. To increase affordability and reach, Company launched Electro+ Rehydrate 160ml. Recognising the widespread reliance on oral medication for menstrual pain - often with side effects, Amrutanjan launched the Comfy Period Pain Relief Roll-On: Ayurvedic, side-effect-free, topical solution. A key milestone was the rapid expansion of the Quick Commerce (QCOM) channel, enabling delivery within minutes and reinforcing the brand's promise of `relief in 10 minutes.